BDBM72387 Step A: 2,8,9-Trifluoro-15,19-dioxo-10,11,12,13,14,15-hexahydro-19H-5,18-methano-dibenzo [f,i]pyrido[2,3-b][1,4,8]triazacyclotridecine-3-carbonitrile::US20250368647, Example 99

SMILES N#Cc1cc2c(cc1F)C(=O)N1CN2c2ccc(F)c(F)c2CCCNc2[nH]c(=O)ccc21

InChI Key InChIKey=NPCKDCVZERYMHW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72387   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72387BDBM72387(Step A: 2,8,9-Trifluoro-15,19-dioxo-10,11,12,13,14...)
Affinity DataIC50: 20nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
PCBioAssay